Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is T  [Clear All Filters]
Tian, J.-X., Zhang, P., Miao, W.-J., Wang, X.-D., Liu, X.-O., Liao, Y.-X., Li, S., and Yan, H.-H. (2019). Tacrolimus levels in the prophylaxis of acute graft-versus-host disease in Chinese early after hematopoietic stem cell transplantation.Ther Drug Monit.
van den Ameele, J., Krautz, R., and Brand, A.H. (2019). TaDa! Analysing cell type-specific chromatin in vivo with Targeted DamID.Curr Opin Neurobiol56, 160-166.
Seruggia, D., Oti, M., Tripathi, P., Canver, M.C., LeBlanc, L., Di Giammartino, D.C., Bullen, M.J., Nefzger, C.M., Sun, Y.Bo Yang, Farouni, R., et al. (2019). TAF5L and TAF6L Maintain Self-Renewal of Embryonic Stem Cells via the MYC Regulatory Network.Mol Cell.
Pemmaraju, N., Lane, A.A., Sweet, K.L., Stein, A.S., Vasu, S., Blum, W., Rizzieri, D.A., Wang, E.S., Duvic, M., J Sloan, M., et al. (2019). Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm.N Engl J Med380, 1628-1637.
Economides, M.P., McCue, D., Lane, A.A., and Pemmaraju, N. (2019). Tagraxofusp, the first CD123-targeted therapy and first targeted treatment for blastic plasmacytoid dendritic cell neoplasm.Expert Rev Clin Pharmacol.
Bhargav, A., San Min, K.-, Feng, L.Wen, Fuh, J.Ying Hsi, and Rosa, V. (2019). Taguchi's methods to optimize the properties and bioactivity of 3D printed polycaprolactone/mineral trioxide aggregate scaffold: Theoretical predictions and experimental validation.J Biomed Mater Res B Appl Biomater.
Martinez-Redondo, P., and Belmonte, J.Carlos Izp (2019). Tailored chromatin modulation to promote tissue regeneration.Semin Cell Dev Biol.
Lu, N., Lu, Y., Liu, S., Jin, C., Fang, S., Zhou, X., and Li, Z. (2019). Tailor-Engineered POSS-based Hybrid Gels for Bone Regeneration.Biomacromolecules.
Sin-Chan, P., Mumal, I., and Huang, A. (2019). Tails of a Super Histone.Cancer Cell35, 7-9.
Stratton, J.Anne, Shah, P., Sinha, S., Crowther, E., and Biernaskie, J. (2019). A tale of two cousins: Ependymal cells, quiescent neural stem cells and potential mechanisms driving their functional divergence.Febs J.
Hu, B. (2019). A tale of two eras: the story of autologous stem cell transplantation with and without thiotepa for primary central nervous system lymphoma.Biol Blood Marrow Transplant.
Gagelmann, N., Eikema, D.-J., Koster, L., Caillot, D., Pioltelli, P., Lleonart, J.Bargay, Reményi, P., Blaise, D., Schaap, N., Trneny, M., et al. (2019). Tandem autologous stem cell transplantation improves outcome in newly diagnosed multiple myeloma with extramedullary disease and high-risk cytogenetics: a study from the Chronic Malignancies Working Party of EBMT.Biol Blood Marrow Transplant.
Giralt, S., Costa, L.J., Maloney, D., Krishnan, A., Fei, M., Antin, J.H., Brunstein, C., Geller, N., Goodman, S., Hari, P., et al. (2019). Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Multiple Myeloma: Long-term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0102 Trial.Biol Blood Marrow Transplant.
Choi, J.Yoon, Kang, H.Jin, Hong, K.Taek, Hong, C.Ry, Lee, Y.Jeong, Park, J.Dong, Phi, J.Hoon, Kim, S.-K., Wang, K.-C., Kim, I.Han, et al. (2019). Tandem high-dose chemotherapy with topotecan-thiotepa-carboplatin and melphalan-etoposide-carboplatin regimens for pediatric high-risk brain tumors.Int J Clin Oncol.
Freeman, A.F., Yazigi, N., Shah, N.N., Kleiner, D.E., Parta, M., Atkinson, P., Heller, T., Holland, S.M., Kaufman, S.S., Khan, K.M., et al. (2019). Tandem Orthotopic Living Donor Liver Transplantation Followed by Same Donor Haploidentical Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency: Tandem Liver and Bone Marrow Transplant in DOCK8 Deficiency.Transplantation.
Nasiri, N., Hosseini, S., Alini, M., Khademhosseini, A., and Eslaminejad, M.Baghaban (2019). Targeted Cell Delivery for Articular Cartilage Regeneration and Osteoarthritis Treatment.Drug Discov Today.
Liao, Y., Ma, Z., Zhang, Y., Li, D., Lv, D., Chen, Z., Li, P., Ai-Dherasi, A., Zheng, F., Tian, J., et al. (2019). Targeted deep sequencing from multiple sources demonstrates increased NOTCH1 alterations in lung cancer patient plasma.Cancer Med.
Bai, M., Han, Y., Wu, Y., Liao, J., Li, L., Wang, L., Li, Q., Xing, W., Chen, L., Zou, W., et al. (2019). Targeted genetic screening in mice through haploid embryonic stem cells identifies critical genes in bone development.Plos Biol17, e3000350.
Hwang, S.Mee, Kim, S.-M., Nam, Y., Kim, J., Kim, S., Ahn, Y.-O., Park, Y., Yoon, S.-S., Shin, S., Kwon, S., et al. (2019). Targeted sequencing aids in identifying clonality in chronic myelomonocytic leukemia.Leuk Res84, 106190.
Mathot, F., Shin, A.Y., and van Wijnen, A.J. (2019). Targeted stimulation of MSCs in peripheral nerve repair.Gene.
McCarthy, S.D.S., Leontyev, D., Nicoletti, P., Binnington, B., Kozlowski, H.N., Ostrowski, M., Cochrane, A., Branch, D.R., and Wong, R.W. (2019). Targeting ABL1 or ARG Tyrosine Kinases to Restrict HIV-1 Infection in Primary CD4+ T-Cells or in Humanized NSG Mice.J Acquir Immune Defic Syndr82, 407-415.
Bort, A., Sánchez, B.G., Mateos-Gómez, P.A., Vara-Ciruelos, D., Rodríguez-Henche, N., and Díaz-Laviada, I. (2019). Targeting AMP-activated kinase impacts hepatocellular cancer stem cells induced by long-term treatment with sorafenib.Mol Oncol.
Xu, Q., Long, Q., Zhu, D., Fu, D., Zhang, B., Han, L., Qian, M., Guo, J., Xu, J., Cao, L., et al. (2019). Targeting amphiregulin (AREG) derived from senescent stromal cells diminishes cancer resistance and averts programmed cell death 1 ligand (PD-L1)-mediated immunosuppression.Aging Celle13027.